showed a trendp=0.050
The RIPC group also showed a trend towards improved stroke/TIA recurrence-free survival compared with the control group (IPTW-adjusted HR, 0.52; 95% CI 0.06 to 1.00; p=0.050).
The RIPC group also showed a trend towards improved stroke/TIA recurrence-free survival compared with the control group (IPTW-adjusted HR, 0.52; 95% CI 0.06 to 1.00; p=0.050).